PsaeA.18222.a
Glutamine--tRNA ligase (EC 6.1.1.18) (Glutaminyl-tRNA synthetase) (GlnRS)
CENTER ID:
PsaeA.18222.a
ORGANISM:
Pseudomonas aeruginosa PAO1
ASSOCIATED DISEASE:
Pseudomonas infection
CURRENT STATUS:
in PDB
COMMUNITY REQUEST:
True
NIH RISK GROUP:
unclassified
SELECT AGENT:
False
NIH PRIORITY
pathogens category:
unclassified
Ordering Clones & Proteins
If there are materials available for this target, they will be listed below.
Materials can be ordered from SSGCID using the button in the "order material" column.
Clicking the button will add the material to a virtual cart.
You may order multiple materials at a time at no cost to you, as this contract is funded
by NIAID. When you are ready to place your order, click the "Place Order" link which will
appear in the top right corner of the page after you place your first item in your cart.
Clones*
CENTER REFERENCE ID
DOMAIN/REGION DESCRIPTION
INFO
AA START
AA STOP
ORDER MATERIAL
PsaeA.18222.a.B1.GE38532
full length
info
1
556
PsaeA.18222.a.B1.GE38532
* SSGCID clones represent un-induced expression constructs which have been verified by sequencing from vector primers. Clones may contain a tag, such as N-term 6xHis . Get sequence information
using the button in the "info" column.
Proteins
CENTER REFERENCE ID
DOMAIN/REGION DESCRIPTION
INFO
AA START
AA STOP
ORDER MATERIAL
PsaeA.18222.a.B1.PW37623
full length
info
1
556
PW37623
Structures
5BNZ
DEPOSITED: 5/26/2015
DETERMINATION: XRay
CLONE: PsaeA.18222.a.B1.GE38532
PROTEIN: PsaeA.18222.a.B1.PW37623
Publications by SSGCID
Glutaminyl-tRNA synthetase from Pseudomonas aeruginosa: Characterization, Structure, and Development as a Screening Platform
Abendroth J, Dranow DM, Bullard JM, Escamilla Y, Hughes CA, Balboa S, Dean F
Protein Sci. - 2019
volume 29, issue 4, pages 905-918
Sequences
These sequences are the native gene sequence; sequences of constructs derived from these sequences may differ due to codon optimization or other protocols.
To find the specific sequence of any material you may have ordered, click on the "info" button next to the name of that material.
AA Sequence
MSKPETTAAP NFLRQIVQAD LDAGKHAKIV TRFPPEPNGY LHIGHAKSIC LNFGLAQEFA GDCHLRFDDT NPAKEDQEYI DAIEADIKWL GFQWSGEVCY ASNYFDQLHA WAVELIKAGK AFVCDLGPEE MREYRGTLTE PGRNSPYRDR SVEENLDLFA RMKAGEFPDG ARSLRAKIDM GSPNMNLRDP ILYRIRHAHH HQTGDKWCIY PSYDFTHGQS DAIEGITHSI CTLEFEDHRP LYEWFLANLP VPAQPRQYEF SRLNLNYTVT SKRKLKQLVD EGHVSGWDDP RMSTLSGYRR RGYTPESIRN FCEMIGVNRA SGVVDIGMLE FSIRDHLDAT APRAMCVLKP LKVVITNYPE GQVENLELPR HPKEDMGVRV LPFGRELFID AGDFEEVPPA GYKRLIPGGE VRLRGSYVIR ADEAIKDADG NIVELRCSYD PDTLGKNPEG RKVKGVIHWV PAEGSVECEV RLYDRLFRSA NPEKAEEGGS FLDNINADSL QVLAGCRAEP SLGQANPEDR FQFEREGYFV ADLKDSRPGK PVFNRTVTLR DSWGQG
NT Sequence
atgagcaagc cagagaccac cgccgccccg aacttcctgc gccagatcgt tcaagccgac ctggatgccg gcaagcacgc gaagatcgtc acccgtttcc ccccggagcc caacggttac ctgcacatcg gccacgccaa gtcgatctgc ctgaacttcg gcctggccca ggaattcgct ggcgattgcc atctgcgctt cgatgacacc aacccggcca aggaagacca ggagtacatc gatgccatcg aggccgacat caagtggctg ggcttccagt ggtccggcga ggtctgctat gcctccaact atttcgacca gctgcatgcc tgggccgtcg agctgatcaa ggccggcaag gcgttcgtct gcgacctcgg tcccgaggaa atgcgcgaat accgcggcac cctcaccgag ccgggccgca acagccctta ccgtgaccgt tcggtggagg agaacctcga cctgttcgcc cgcatgaagg ccggtgagtt ccccgacggc gcccgttcgc tgcgggcgaa gatcgacatg ggttcgccga acatgaacct gcgcgatccg atcctgtacc gcatccgcca tgcgcatcac caccagaccg gcgacaagtg gtgcatctac ccgagctacg acttcaccca cggtcagtcg gacgccatcg agggcatcac ccattcgatc tgcaccctgg aattcgaaga ccatcgtccg ctctacgagt ggttcctggc caacctgccg gtacctgcgc aaccgcgcca gtacgaattc tcccggctca acctgaacta caccgtgacc agcaagcgca agctcaagca attggtcgac gaaggccatg tcagcggctg ggacgatccg cgcatgtcga ccctgtccgg ctatcgccgc cgcggctaca ccccggagtc gatccgcaac ttctgcgaga tgatcggggt gaaccgcgcc agcggcgtgg tcgacatcgg catgctcgag ttcagcatcc gcgaccacct ggacgccacc gcgccgcgtg ccatgtgcgt gctgaaaccg ctcaaggtgg tgatcaccaa ctaccccgaa gggcaggtgg agaacctcga gttgccgcgt catccgaagg aagacatggg agtgcgcgta ctgccgttcg gtcgcgagct gttcatcgat gccggtgact tcgaggaagt cccgccggcc ggctacaagc gcctgatccc cggtggcgag gtgcgtctgc gcggcagcta cgtgatccgt gccgacgaag cgatcaagga tgccgacggc aatatcgtcg aactgcgctg cagctacgat ccggacaccc tgggcaagaa cccggaaggc cgcaaggtca agggcgtgat ccactgggtg ccggccgagg gcagcgtcga gtgcgaagtg cgcctgtacg atcggctgtt ccgctcggcc aatccggaga aggcggaaga gggcggcagc ttcctcgaca acatcaacgc cgactccctg caggtactgg ccggctgtcg cgccgagccg tcgctgggcc aggcgaaccc ggaggatcgc ttccagttcg agcgcgaagg ctatttcgtc gccgacctga aggactccag gccgggcaag ccggtgttca accgtaccgt caccctgcgt gactcctggg gacagggctg a
Details for PsaeA.18222.a.B1.GE38532
HARVESTED ON:
10/9/2014
SEQUENCED ON:
11/24/2014
EXPECTED MW:
64kDa
OBSERVED MW:
64kDa
ANTIBIOTIC MARKER:
ampicillin
COUNT OF EXPRESSION COLONIES:
Too many to count (100+)
TOTAL EXPRESSION LEVEL:
Moderate Expression
SOLUBLE EXPRESSION LEVEL
High Expression
EXPRESSION HOST:
data unavailable
SEQUENCING RESULT:
PERCENT IDENTITY:
71
PERCENT COVERAGE:
57
Details for PsaeA.18222.a.B1.PW37623
PURIFICATION DATe:
1/5/2015
CONCENTRATION:
31mg/ml
OBSERVED MW:
64kDa
EXPRESSION LEVEL:
Moderate Expression
PROTEIN PURIFICATION BUFFER:
25 mM HEPES pH 7.0, 500 mM NaCl, 5% Glycerol , 2 mM DTT, and 0.025% Azide
EXPRESSION HOST:
data unavailable
VIAL COUNT (approx.):
9
VIAL VOLUME:
200µl
PERCENT IDENTITY:
71
PERCENT COVERAGE:
57